Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

Published:2008-08-08 Issue:18 Volume:51 Page:5471-5489
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kodimuthali Arumugam¹,Jabaris S. Sugin Lal¹,Pal Manojit¹

Affiliation:

1. New Drug Discovery, R & D Center, Matrix Laboratories Limited, Anrich Industrial Estate, Bollaram, Jinnaram Mandal, Medak District, Andhra Pradesh, 502 325, India

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm800582j

Reference126 articles.

1. Treatment of stable chronic obstructive pulmonary disease

2. Management of Chronic Obstructive Pulmonary Disease

3. The Next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases

4. Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26

2. Rhodanine-benzamides as potential hits for α-amylase enzyme inhibitors and radical (DPPH and ABTS) scavengers;Molecular Diversity;2024-03-06

3. New phosphodiesterase-4 inhibitors present airways relaxant activity in a guinea pig acute asthma model;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-18

4. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes;International Journal of Molecular Sciences;2023-07-15

5. THE PRECLINICAL JOURNEY OF MET INHIBITORS;2022 Medicinal Chemistry Reviews;2022-12-21